首页> 外文期刊>Balkan Medical Journal >Prognosis and Risk Factors of Coronary Artery Lesions before Immunoglobulin Therapy in Children with Kawasaki Disease
【24h】

Prognosis and Risk Factors of Coronary Artery Lesions before Immunoglobulin Therapy in Children with Kawasaki Disease

机译:川崎病儿童免疫球蛋白治疗前冠状动脉病变的预后及危险因素

获取原文
           

摘要

Background: Many children with Kawasaki disease develop coronary artery lesions before intravenous immunoglobulin treatment. However, little data are available on the prognosis of children with Kawasaki disease who developed coronary artery lesions before intravenous immunoglobulin treatment. Aims: To explore the outcomes of coronary artery lesions before intravenous immunoglobulin treatment in children with Kawasaki disease and analyze the factors that influence the duration of coronary artery lesions. Study Design: Retrospective cohort study. Methods: All patients with Kawasaki disease who developed coronary artery lesions before intravenous immunoglobulin treatment in our hospital from January 2009 to December 2014 were reviewed. A Cox proportional hazards model was used to determine the factors influencing the prognosis of coronary artery lesions. Results: Among 182 patients included, 28.6% were male, 83.50% were younger than 36 months, and 181 exhibited resolution of coronary artery lesions 2 years after disease onset. The median duration of coronary artery lesions was 31 days, and the proportion of coronary artery lesions was 52% at 1 month, 35% at 2 months, 33% at 3 months, 25% at 6 months, 14% at 1 year, and 0.5% at 2 years. The univariate analysis showed that overweight status, higher platelet count, lower albumin level, and starting treatment more than 10 days after disease onset were factors that possibly affect the duration of coronary artery lesions in children. The multivariate Cox regression analysis showed that female sex (adjusted hazard ratio, 1.661; 95% confidence interval, 1.117-2.470) was an independent protective factor, and overweight status (adjusted hazard ratio, 0.469; 95% confidence interval, 0.298-0.737), higher platelet count (adjusted hazard ratio, 0.649; 95% confidence interval, 0.443-0.950), and starting treatment more than 10 days after disease onset (adjusted hazard ratio, 0.392; 95% confidence interval, 0.215-0.716) were independent risk factors for a longer duration of coronary artery lesions. Conclusion: The average duration of coronary artery lesions before intravenous immunoglobulin therapy in children with Kawasaki disease is approximately 1 month. Male gender, overweight status, higher platelet count, and initiation of treatment more than 10 days after the onset of the disease are independent risk factors for longer-lasting coronary artery lesions.
机译:背景:许多汗崎疾病的儿童在静脉内免疫球蛋白治疗前发育冠状动脉病变。然而,在静脉内免疫球蛋白治疗之前开发了川崎病的儿童预后,少量数据可以获得冠状动脉病变。目的:探讨川崎病儿童静脉内免疫球蛋白治疗前冠状动脉病变的结果,分析了影响冠状动脉病变持续时间的因素。研究设计:回顾性队列研究。方法:综述了所有川崎病患者,患有冠状动脉病变的冠状动脉病变从2009年1月至2014年12月介绍了静脉内免疫球蛋白治疗。使用Cox比例危害模型来确定影响冠状动脉病变预后的因素。结果:182名患者中,28.6%是男性,83.50%比36个月更年轻,181名患有疾病发作后2年的冠状动脉病变的决议。冠状动脉病变的中位持续时间为31天,冠状动脉病变的比例在1个月内为52%,2个月,3个月,33%,25%,6个月,1年,1年,1年2年后0.5%。单变量分析表明,疾病发作后超过10天的超重状况,更高的血小板计数,低白蛋白水平和起始治疗是可能影响儿童冠状动脉病变的持续时间的因素。多元COX回归分析显示,女性(调整后危险比为1.661; 95%置信区间,1.117-2.470)是独立的保护因子,超重状态(调整危险比,0.469; 95%置信区间,0.298-0.737) ,血小板计数较高(调整危险比,0.649; 95%置信区间,0.443-0.950)和疾病发病后超过10天的起始治疗(调整后危险比,0.392; 95%置信区间,0.215-0.716)是独立的风险冠状动脉病变较长持续时间的因素。结论:川崎病儿童静脉内免疫球蛋白治疗前冠状动脉病变的平均持续时间约为1个月。男性性别,超重状况,血小板计数更高,治疗的启动超过10天后,疾病发作是持久冠状动脉病变的独立风险因素。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号